Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fleming

Showing results (821-830 of 862) with videos related to

Pageof 87
Sort By:
Journal of the American College of Cardiology|June 27, 2009
End points and clinical trial design in pulmonary arterial hypertensionVallerie V McLaughlin, David B Badesch, Marion Delcroix, et al.
Clinical Trials (London, England)|July 22, 2022
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threatsIra M Longini, Yang Yang, Thomas R Fleming, et al.
The Journal of Physical Chemistry Letters|May 16, 2022
Concerted Electron-Nuclear Motion in Proton-Coupled Electron Transfer-Driven Grotthuss-Type Proton TranslocationEric A Arsenault, Walter D Guerra, James Shee, et al.
Nature Medicine|April 28, 2026
Clinical trials for continuously monitored and updated AI systemsWouter A C van Amsterdam, Michael Oberst, Jean Feng, et al.
Blood|November 18, 2006
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host diseaseMargaret L Macmillan, Daniel Couriel, Daniel J Weisdorf, et al.
Human Mutation|March 1, 2020
Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic featuresRami A Ballout, Cheryl Dickerson, Myra J Wick, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2017
Prospective Evaluation of Kidney Disease in Joubert SyndromeLeah R Fleming, Daniel A Doherty, Melissa A Parisi, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Nature Genetics|October 23, 2012
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancyGiulia Barcia, Matthew R Fleming, Aline Deligniere, et al.
Pageof 87

Showing results (821-830 of 862) with videos related to

Sort By:
Pageof 87
Journal of the American College of Cardiology|June 27, 2009
End points and clinical trial design in pulmonary arterial hypertensionVallerie V McLaughlin, David B Badesch, Marion Delcroix, et al.
Clinical Trials (London, England)|July 22, 2022
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threatsIra M Longini, Yang Yang, Thomas R Fleming, et al.
The Journal of Physical Chemistry Letters|May 16, 2022
Concerted Electron-Nuclear Motion in Proton-Coupled Electron Transfer-Driven Grotthuss-Type Proton TranslocationEric A Arsenault, Walter D Guerra, James Shee, et al.
Nature Medicine|April 28, 2026
Clinical trials for continuously monitored and updated AI systemsWouter A C van Amsterdam, Michael Oberst, Jean Feng, et al.
Blood|November 18, 2006
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host diseaseMargaret L Macmillan, Daniel Couriel, Daniel J Weisdorf, et al.
Human Mutation|March 1, 2020
Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic featuresRami A Ballout, Cheryl Dickerson, Myra J Wick, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2017
Prospective Evaluation of Kidney Disease in Joubert SyndromeLeah R Fleming, Daniel A Doherty, Melissa A Parisi, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Nature Genetics|October 23, 2012
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancyGiulia Barcia, Matthew R Fleming, Aline Deligniere, et al.
Pageof 87